4.5 Article

Gonococcal transferrin binding protein chimeras induce bactericidal and growth inhibitory antibodies in mice

Journal

VACCINE
Volume 25, Issue 41, Pages 7247-7260

Publisher

ELSEVIER SCI LTD
DOI: 10.1016/j.vaccine.2007.07.038

Keywords

TonB-dependent transporter; Neisseria gonorrhoeae; iron; cholera toxin; vaccine

Funding

  1. NIAID NIH HHS [R01-AI047141, R01 AI046561, R01 AI047141, R01-AI46561, T32 AI007617, R01 AI047141-07] Funding Source: Medline
  2. NIDCR NIH HHS [R01-DE06746, R37 DE006746] Funding Source: Medline
  3. PHS HHS [T32 AIO7617] Funding Source: Medline

Ask authors/readers for more resources

We have previously demonstrated the full-length gonococcal transferrin binding proteins (TbpA and TbpB) to be promising antigens in the development of a protective vaccine against Neisseria gonorrhoeae. In the current study we employed a genetic chimera approach fusing domains from TbpA and TbpB to the A2 domain of cholera toxin, which naturally binds in a non-covalent fashion to the B subunit of cholera toxin during assembly. For one construct, the N-terminal half of TbpB (NB) was fused to the A2 subunit of cholera toxin. In a second construct, the loop 2 region (L2) of TbpA was genetically fused between the NB domain and the A2 domain, generating a double chimera. Both chimeras were immunogenic and induced serum bactericidal and vaginal growth-inhibiting antibodies. This study highlights the potential of using protective epitopes instead of full-length proteins in the development of an efficacious gonococcal vaccine. (c) 2007 Elsevier Ltd. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available